Hyperenterostatinemia in premenopausal obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 937-941

  Prasad, Chandan ^a   Imamura, M ^a   Debata, C ^a   Svec, F ^a   Sumar, N ^b   Hermon Taylor, J ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROSTATIN; FAT;

ADULT; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE RESISTANCE; HORMONE SYNTHESIS; HUMAN; IMMUNOREACTIVITY; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REGULATORY MECHANISM;

EID: 0032989983     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.937     Document Type: Article

References (34)

1. Stevens J. 1995 Obesity, fat patterning and cardiovascular risk. Adv Exp Med Biol. 369:21-27.
2. Schindler AE. 1997 Obesity and cancer risk in women. Arch Gynecol Obstet. 261:21-24.
3. Pujol P, Galtier-Dereure F, Bringer J. 1997 Obesity and breast cancer risk. Hum Reprod. 12(Suppl 1):116-125.
4. Cleary MP, Maihle NJ. 1997 The role of body mass index in the relative risk of developing premenopausal vs. postmenopausal breast cancer. Proc Soc Exp Biol Med. 216:28-43.
5. Amanti M, Schumann L. 1998 Coronary artery disease: a link between hypertension, diabetes mellitus, hyperlipidemia, and obesity. J Am Acad Nurse Pract. 10:77-81.
6. Lichtenstein AH, Kennedy E, Barrier P, et al. 1998 Dietary fat consumption and health. Nutr Rev. 56:S3-28.
7. Roberts SB, Pi-Sunyer FX, Dreher M, et al. 1998 Physiology of fat replacement and fat reduction: effects of dietary fat and fat substitutes on energy regulation. Nutr Rev. 56:S29-41.
8. Reed DR, Bachmanov AA, Beauchamp GK, Tordoff MG, Price RA. 1997 Heritable variation in food preferences and their contribution to obesity. Behav Genet. 27:373-387.
9. Lawton CL, Blundell JE. 1998 The role of reduced fat diets and fat substitutes in the regulation of energy and fat intake and body weight. Curr Opin Lipidol. 9:41-45.
10. Willett WC. 1998 Is dietary fat a major determinant of body fat?. Am J Clin Nutr. 67(Suppl 3):556S-562S.
11. Seidell JC. 1998 Dietary fat and obesity: an epidemiologic perspective. Am J Clin Nutr. 67(Suppl 3):546S-550S.
12. Bray GA. 1992 Peptides affect the intake of specific nutrients and the sympathetic nervous system. Am J Clin Nutr. 55(Suppl 1):265S-271S.
13. Blundell JE, Lawton CL. 1995 Serotonin and dietary fat intake: effects of dexfenfluramine. Metabolism. 44(Suppl 2):33-37.
14. Blundell JE, Lawton CL, Halford JC. 1995 Serotonin, eating behavior, and fat intake. Obesity Res. 3(Suppl 4):471S-476S.
15. Sorhede M, Mei J, Erlanson-Albertsson C. 1993 Enterostatin: a gut-brain peptide regulating fat intake in rat. J Physiol. 87:273-275.
16. Erlanson-Albertsson C. 1992 Enterostatin: the pancreatic procolipase activation peptide - a signal for regulation of fat intake. Nutr Rev. 50:307-310.
17. Erlanson-Albertsson C. 1994 Pancreatic lipase, colipase and enterostatin - a lipolytic triad. In: Mackness MI, Clerc M, eds. Esterases, lipases and phospholipases: from structure to clinical significance. New York: Plenum Press; 159-168.
18. Erlanson-Albertsson C. 1992 Pancreatic colipase. Structural and physiological aspects. Biochim Biophys Acta. 1125:1-7.
19. Erlanson-Albertsson C, Mei J, Okada S, York D, Bray GA. 1991 Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav. 49:1191-1194.
20. Okada S, York DA, Bray GA. Erlanson-Albertsson C. 1991 Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiol Behav. 49:1185-1189.
21. Shargill NS, Tsujii S, Bray GA. Erlanson-Albertsson C. 1991 Enterostatin suppresses food intake following injection into the third ventricle of rats. Brain Res. 544:137-140.
22. Bowyer RC, Jehanli AMT, G. Patel G, Hermon-Taylor J. 1991 Development of enzymelinked immunosorbent assay for free human procolipase activation peptide (APGPR). Clin Chim Acta. 200:137-152.
23. Mizuma H, Imamura M, Tiemann WE, Prasad C. 1995 Biology of enterostatin. II. Development of enzyme-linked immunosorbentassay (ELISA) for enterostatin (Val-Pro-Asp-Pro-Arg), the procolipase activation peptide. Biochem Biophys Res Commun. 215:227-234.
24. Strazzulla G, Guazzelli R, Romano S, et al. 1990 Circadian variations of plasma somatostatin levels in healthy subjects. Chronobiologia. 17:219-225.
25. Azukizawa M, Mitsuma T, Ota M, et al. 1980 Fluctuation of the plasma TRH level in normal subjects in a 4-hour observation period. Endocrinol Jpn. 27:371-374.
26. Manfredi R, Vezzadini P, Costigliola P, et al. 1993 Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea. Effects of treatment with octreotide. AIDS. 7:223-226.
27. Nystrom F, Nilsson P, Olsson AG, et al. 1996 A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome. Blood Pressure. 5:349-353.
28. Imamura M, Sumar N, Hermon-Taylor J, et al. 1998 Distribution and characterization of enterostatin-like immunoreactivity in human cerebrospinal fluid. Peptides. 19:1385-1391.
29. Sorhede M, Erlanson-Albertsson C, Mei J, Nevalainen T, Aho A, Sundler F. 1996 Enterostatin in gut endocrine cells-immunocytochemical evidence. Peptides. 17:609-614.
30. Sorhede M, Mulder H, Mei J, Sundler F, Erlanson-Albertsson C. 1996 Procolipase is produced in the rat stomach-a novel source of enterostatin. Biochim Biophys Acta. 1301:207-212.
31. Okada S, York DA, Bray GA. 1993 Procolipase mRNA: tissue localization and effects of diet and adrenalectomy. Biochem J. 292:787-789.
32. Lin L, Chen J, York DA. 1997 Chronic ICV enterostatin preferentially reduced fat intake and lowered body weight. Peptides. 18:657-661.
33. Nagase H, Bray GA, York DA. 1996 Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res. 709:44-50.
34. Tian Q, Nagase H, York DA, Bray GA. 1994 Vagal-central nervous system interactions modulate the feeding response to peripheral enterostatin. Obesity Res. 2:527-534.